Buy 5-MeO-DALT Powder

Product Overview

5-MeO-DALT Powder offers 5-methoxy-N,N-diallyltryptamine (5‑MeO‑DALT) as a high-purity, small‑molecule research chemical tailored to laboratories working with emerging and controlled tryptamine derivatives. The compound has been documented as a ring‑substituted N,N‑diallyltryptamine, most often encountered in the context of “research chemical” markets and forensic casework, which underscores its relevance as an analytical and toxicological reference material.

Supplied as a brandless ≥98% purity solid, this product is positioned for non-clinical research only and is not developed or presented as a pharmaceutical, dietary, or consumer product. All work with 5‑MeO‑DALT Powder must be conducted by trained personnel in appropriately licensed laboratories operating under institutional oversight, with no implication of suitability for exposure in humans or animals. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

5-MeO-DALT (5-methoxy-N,N-diallyltryptamine) is a substituted tryptamine characterized by a 5‑methoxy group on the indole ring and two allyl groups on the terminal amine. Technical briefings describe it as a ring‑substituted N,N‑diallyltryptamine structurally related to a wide range of psychoactive, synthetic, and naturally occurring N,N‑dialkylated tryptamines.

Key identifiers include:

• Preferred name: 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT)

• CAS number: 928822-98-4

• Molecular formula: C17H22N2O

• Molecular weight: ~270.37–270.4 g/mol

• Representative synonyms: 5-Methoxy DALT; 5-methoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine; 5-methoxy-N,N-di-2-propen-1-yltryptamine; N,N-diallyl-5-methoxytryptamine.

In a research setting, 5-MeO-DALT is typically classified as:

• A synthetic tryptamine and ring-substituted N,N-diallyltryptamine research chemical.

• A small-molecule analyte of interest in forensic toxicology, NPS monitoring, and analytical method development.

Chemical & Physical Characteristics

According to international technical briefings, 5-MeO-DALT is described as a white or yellow powder, consistent with a solid indole-based organic compound. Its molecular formula C17H22N2O and molecular weight around 270.4 g/mol align with characterization data compiled in monographs and chemical databases.

The presence of the 5‑methoxy substituent and diallyl tertiary amine side chain influences lipophilicity, basicity, and potential salt‑forming behavior, which in turn affect solubility and solid-state properties. Crystalline forms of 5‑MeO‑DALT and related fumarate salts have been characterized by X‑ray powder diffraction, indicating distinct and reproducible solid phases relevant to formulation and analytical work. As a powder, typical solubility patterns follow those of tertiary tryptamine derivatives, which often exhibit limited water solubility in freebase form but good compatibility with a range of polar organic solvents used in chromatographic analysis.

Lot-specific information such as precise appearance, any color nuances, and observed thermal behavior (for example, melting range) is normally captured in the certificate of analysis (COA) accompanying research and reference material. These details help laboratories design appropriate sample-preparation procedures and handling protocols for analytical workflows.

Purity & Analytical Verification

5-MeO-DALT Powder is specified at ≥98% purity, consistent with the expectations for high‑grade research chemicals and reference materials used in advanced analytical applications. Forensic and toxicological laboratories rely on such materials to develop and validate detection, identification, and quantification methods for NPS monitoring and casework.

Analytical characterization of 5‑MeO‑DALT in the literature and monographs commonly includes gas chromatography–mass spectrometry (GC‑MS), liquid chromatography–mass spectrometry (LC‑MS), and, where available, infrared (IR) and NMR spectroscopy to confirm identity and structure. Critical review and technical folders document that 5‑MeO‑DALT can be reliably detected and differentiated from structurally related tryptamines using such instrumental techniques, which underscores the importance of well-defined reference material. For research-grade product, a batch-specific COA typically summarizes assay results, impurity limits, and key analytical methods used for release testing.

Quality Control & Batch Integrity

Batch-controlled production of 5-MeO-DALT Powder ensures that each lot can be traced from synthesis through final packaging, with unique identifiers linking physical material to its analytical and safety documentation. This level of traceability is essential for laboratories that must document reference material usage in regulated or quality-managed environments.

Technical monographs and cross-country information sheets highlight that 5‑MeO‑DALT has been identified in multiple branded products and mixtures, reinforcing the need for well-characterized, stand‑alone reference compounds for unambiguous analytical confirmation. Quality programs for research material therefore focus on identity, purity, and stability checks as well as labeling accuracy and container integrity, so that end users can rely on consistent composition and performance across different lots.

Safety, Handling & Laboratory Precautions

5-MeO-DALT Powder is intended exclusively for use by trained professionals within suitably equipped laboratory facilities. Standard good laboratory practice (GLP) should be followed, including use of appropriate personal protective equipment such as gloves, protective eyewear, and lab coats, and, where required, work within fume hoods or other engineering controls.

Substance briefings describe 5‑MeO‑DALT as a hallucinogenic tryptamine and document its involvement in recreational contexts, emphasizing that it is a controlled or monitored NPS in many jurisdictions. As such, laboratories should consult the substance-specific safety data sheet (SDS) for detailed hazard classification, exposure-control recommendations, spill handling, and waste-disposal guidance, and ensure that internal risk assessments and local regulations are fully respected. No guidance is provided or implied for dosing, administration, or any clinical or personal use; activities must remain strictly within non-clinical research boundaries.

Packaging, Labeling & Storage

5-MeO-DALT Powder is supplied in sealed, research-grade primary containers designed to protect the material from moisture, light, and physical damage during transport and storage. Containers for analytical and reference materials are typically robust and may incorporate tamper-evident features, supporting verification of integrity upon receipt.

Standard labeling practice includes the chemical name, common abbreviation, CAS number, lot number, and key hazard or precautionary statements, ensuring compliance with chemical safety regulations and facilitating correct cataloging within laboratory inventory systems. Technical documents on 5‑MeO‑DALT recommend storing the compound in a cool, dry place, in a tightly closed container and protected from light, as with other indole-based tryptamines susceptible to degradation. Laboratories should rely on SDS and COA guidance for any batch-specific storage temperatures or re‑test intervals and restrict access to authorized personnel only.

Intended Research Use & Market Positioning

5-MeO-DALT Powder is positioned strictly as a research chemical and analytical reference compound for non-clinical use. It is particularly relevant to forensic toxicology, NPS surveillance, analytical chemistry, and method development where accurate identification and quantification of 5‑MeO‑DALT in complex matrices is required.

The product is not manufactured, marketed, or approved for human or veterinary use and must not be used for clinical, diagnostic, or consumptive applications. Any discussion of psychoactive or hallucinogenic properties in public health, forensic, or pharmacological literature pertains to separate regulatory and clinical contexts, distinct from the research-only intent of this material. End users are expected to understand and comply with all applicable scheduling, licensing, and handling regulations governing 5‑MeO‑DALT in their jurisdiction.

Ordering, Availability & Fulfillment

5-MeO-DALT reference and research materials are typically supplied to professional and institutional customers via specialized chemical and analytical-standard channels. Ordering documentation generally includes the analyte name, CAS number, lot identifier, and pack details, enabling accurate internal record keeping and traceability.

Availability may be influenced by regulatory status, regional controls on NPS compounds, and demand from forensic and toxicology laboratories. Shipments are usually prepared in robust, discreet outer packaging suitable for courier transport, with tracked delivery options that support chain-of-custody requirements where necessary. Suppliers typically provide COAs, SDS files, and limited technical support focused on specifications and analytical characteristics, within the strict limits of non-clinical, research-only guidance.

Legal & Regulatory Disclaimer

This product is supplied strictly as a research chemical for use in laboratory environments by qualified professionals operating under appropriate institutional and regulatory oversight. It is not manufactured, approved, or intended for human or veterinary use and must not be used for clinical, diagnostic, therapeutic, or consumptive applications under any circumstances.

Responsibility for compliance with all applicable local, national, and international laws—including scheduling, licensing, import/export, and controlled-substance regulations related to 5‑methoxy‑N,N‑diallyltryptamine—rests solely with the purchaser and end user. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.